The Centers for Medicare and Medicaid Services (CMS) has again delayed implementation of the Physician Payments Sunshine Act, a requirement of the Affordable Care Act, which requires that drug and medical device companies publicly report their payments to physicians. As a result of the extension, drug and device manufacturers will not be required to collect data on payments to providers until 2013. According to CMS, the decision was made "In order to provide time for organizations to prepare for data submission and to sufficiently address the important input we received during the rulemaking process…” A proposed rule was released by CMS in December and a final rule is expected later this year.
The ACC submitted comments last year in response to an open request for input on the regulations from CMS. Comments were also submitted on the proposed rule in February. The College strongly supports transparency in physician and physician organization relationships with industry, but believes that it is critical this information be placed into the proper context, and made publicly available in a format understandable by the average consumer.
For more information on Advocacy developments, stay tuned to
, read the
ACC in Touch Blog